Expanded Access to NanoPac

NanOlogy

Status

Conditions: Lung Cancer; Prostate Cancer; Locally Advanced Pancreatic Carcinoma

Treatments: Drug: NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT03756311

NANOPAC-EA

Details and patient eligibility

About

NanOlogy may consider offering expanded access to NanoPac for patients who do not meet the enrollment criteria of clinical trials in progress.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

-

Exclusion criteria

-